Over the past 12 months, information about the SARS-CoV-2 virus (or COVID-19 as it is commonly known) continues to emerge. A wealth of information appears on the website of the U.S. Centers for Disease Control and Prevention (2021) about the virus, management, vaccines, quarantine, and new variants. A search of the National Library of Medicine’s (NLM) National Center for Biotechnology Information’s database (PubMed) identified over 90,000 COVID-19 related articles already in print from around the world (NLM, 2021). Approximately 800 clinical trials examining a variety of biologics for COVID-19 intervention are also underway (all phases) worldwide (NLM ClinicalTrials.gov, 2021).
The role of audiology in the management of COVID-19 patients has emerged as survivors begin to experience a continuance of their health issues post-discharge or a late onset of medical problems. This group of patients has been referred to as COVID-19 “long-haulers.” COVID-19 survivors may also experience auditory/vestibular problems. DiSogra (2020) addresses this issue in detail and offers suggestions for ongoing monitoring.
This article will address whether COVID-19 can be found in cerumen and what precautions need to be taken with current patients and ‘long-haulers.’
Recent Posts
Academy Supports Louisiana Legislation to Update Audiology Scope of Practice
The Louisiana legislature is currently considering House Bill 925 (HB 925), introduced during the 2026 regular session. This legislation aims to update statutory definitions related…
Update on Hearing Device Services Codes
As released publicly in the March 10, 2026, AMA’s Errata & Technical Corrections CPT® 2026, the parentheticals related to code 92628 (Evaluation for hearing candidacy)…
Intratympanic Steroid Therapy as a Salvage Treatment for Sudden Sensorineural Hearing Loss
Fernandez et al. (2026) completed a retrospective analysis of 86 patients seen between 2019 and 2024 with sudden sensorineural hearing loss (SSNHL). This analysis compared…


